08.05.19

Alimera Announces Iluvien Regulatory Approval in Australia for the Treatment of DME

Source: Alimera Sciences

08.01.19

Perspective: Protocol V Sheds Light on Managing Mild Diabetic Macular Edema

Source: Medscape

07.19.19

Double-Barreled Biologic for Diabetic Retinopathy Emerging

Source: Medscape

07.01.19

Oxurion NV Reports Topline Phase 1 Results with THR-149 for the treatment of DME

Source: Oxurion NV

06.04.19

Verseon Showcases Oral Candidates for Next-Generation Diabetic Eye Disease Drugs

Source: Verseon

05.22.19

Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign for Iluvien

Source: Alimera Sciences

05.10.19

Watchful Waiting OK in Diabetic Macular Edema With Good Vision

Source: Medscape

04.30.19

Verseon Presents Oral Drug Candidate for Diabetic Eye Disease

Source: Verseon

04.25.19

Full Phase 2 Results Published Showing Efficacy, Safety, & Durability of Faricimab in DME

Source: Roche

04.25.19

Aerie Pharmaceuticals Announces Acceptance of Its IND Application for Sustained-Release Implant for Retinal Diseases

Source: Aerie Pharmaceuticals

View more stories